Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
Luise HolzhauserKevin D ClerkinTakeo FujinoFrancis J AlenghatJayant K RaikhelkarGene KimGabriel SayerNir UrielPublished in: Clinical transplantation (2021)
Higher dd-cfDNA levels were associated with CAV in stable chronic HT recipients. Further studies are warranted to investigate a possible association between dd-cfDNA levels and CAV severity and whether dd-cfDNA can predict CAV progression.